NCT06636760View on ClinicalTrials.gov

Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions
COVID 19
Interventions
OTHER

Placebo

The placebo contains the non-active carrier of herbal combination that has no pharmacological activity.

DIETARY_SUPPLEMENT

herbal compound

The herbal combination is made up of various medicinal plants and possesses immunomodulator properties. It comprises Phyllanthus niruri, Andrographis paniculata, and Glycyrrhiza glabra, along with Anacardium occidentale leaf and Zingiber officinale rhizome, all recognized for their immunomodulatory properties.

Trial Locations (1)

14360

The National Emergency Hospital for COVID-19, Wisma Atlet, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT06636760 - Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery | Biotech Hunter | Biotech Hunter